Volition Announces Breakthrough Finger-Prick Detection of Nucleosomes; Expanding Global Market Potential for Sepsis Testing

Go back to Volition Announces Breakthrough Finger-Prick Detection of Nucleosomes; Expanding Global Market Potential for Sepsis Testing
VolitionRX Limited (NYSE: VNRX) Delayed: 0.76 -0.09 (10.59%)
Previous Close $0.85    52 Week High $5.86 
Open $0.87    52 Week Low $3.05 
Day High $0.88    P/E N/A 
Day Low $0.76    EPS $-0.45 
Volume 121,288